| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.0009 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.14 | 0.001 |